UCB’s Bimzelx Impresses In Psoriatic Arthritis Amid US Psoriasis Approval Delay

 
• By Ayisha Sharma
  
UCB Celebrates Win In Psoriatic Arthritis Even As Regulatory Wait Is Prolonged • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D